UL16 is a tegument protein of herpes simplex virus (HSV) that is conserved among all members of the Herpesviridae, but its function is poorly understood. Previous studies revealed that UL16 is associated with capsids in the cytoplasm and interacts with the membrane protein UL11, which suggested a "bridging" function during cytoplasmic envelopment, but this conjecture has not been tested. To gain further insight, cells infected with UL16-null mutants were examined by electron microscopy. No defects in the transport of capsids to cytoplasmic membranes were observed, but the wrapping of capsids with membranes was delayed. Moreover, clusters of cytoplasmic capsids were often observed, but only near membranes, where they were wrapped to produce multiple capsids within a single envelope. Normal virion production was restored when UL16 was expressed either by complementing cells or from a novel position in the HSV genome. When the composition of the UL16-null viruses was analyzed, a reduction in the packaging of glycoprotein E (gE) was observed, which was not surprising, since it has been reported that UL16 interacts with this glycoprotein. However, levels of the tegument protein VP22 were also dramatically reduced in virions, even though this gE-binding protein has been shown not to depend on its membrane partner for packaging. Cotransfection experiments revealed that UL16 and VP22 can interact in the absence of other viral proteins. These results extend the UL16 interaction network beyond its previously identified binding partners to include VP22 and provide evidence that UL16 plays an important function at the membrane during virion production.
I
nfectious herpesviruses contain approximately 40 viral proteins and are produced when their DNA-containing capsids are wrapped with a cell-derived membrane in the cytoplasm (1) . This envelopment process is driven by complex interactions that are still poorly understood but is known to involve bridging interactions provided by a growing list of tegument proteins, which provide linkages between the capsid and viral membrane proteins (1) (2) (3) . The UL16 tegument protein of herpes simplex virus (HSV) is remarkable for its numerous interactions with several other viral proteins, namely, tegument protein UL21 (4, 5) , membrane protein UL11 (4, (6) (7) (8) , membrane glycoprotein E (gE) (4, 9) , and an unidentified protein(s) that is associated with the capsid (10) (11) (12) . UL16 is conserved among all the alpha-, beta-, and gammaherpesvirinae (2, 13, 14) , but its actual function remains unknown.
There are several reasons for suggesting a role for UL16 in HSV envelopment. The earliest study showed that a U L 16-null mutant (here named the ⌬U L 16B mutant) produces infectious virions at a level only one-tenth that of the wild-type virus (15) . Also, UL16 has been shown to be bound in some manner to cytoplasmic capsids (10, 16, 17) , and thus, its direct interactions with membrane proteins UL11 (8) and gE (9) suggest that UL16 might provide bridging functions that help drive virion production, as first proposed 10 years ago (7) . This model is consistent with the observation that gE-and UL11-null mutants both exhibit reductions in the level of virion production (12, (18) (19) (20) (21) (22) . Finally, studies of several UL16 homologs have revealed defects in virion production when they are absent. In particular, in the cases of human cytomegalovirus (23) , mouse cytomegalovirus (MCMV) (24) , and murine gammaherpesvirus 68 (13) , electron microscopy of null mutants revealed that capsids were not associated with membranes, and hence, no enveloped virions were seen. However, these studies suggest that the block to virion production occurs prior to transport to the membrane for mutant viruses. In the case of alphaherpesviruses that lack UL16, reduced numbers of infectious virions are produced for HSV and pseudorabies virus (15, 25) , but the location of the inefficient egress step has not been identified.
In this study, mutants lacking the U L 16 gene of HSV-1 were studied in order to ascertain the effects on virion morphogenesis, composition, viral replication, and viral protein expression and packaging. The results revealed an inefficient envelopment step in the cytoplasm after capsids arrived at the membrane. Unexpectedly, a defect in virion packaging was found for another tegument protein, VP22, which is encoded by the U L 49 gene (26) . VP22 is a phosphorylated protein that is known to interact within a network that includes gE, gD, VP16, ICP0, and gM (8, 9, (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . It also binds to and negatively regulates "virion host shutoff" (VHS) protein, and thus, mutants that lack VP22 have defects in virus production and exhibit reduced protein synthesis (36, 37) . Because no evidence to link the VP22 and UL16 interaction networks has been reported, we investigated the possibility that these two proteins interact. Here we report the first evidence that they can. Although these results add to the bewildering number of viral protein interactions that need to be studied in depth, it is clear that UL16 does play a role at the membrane during envelopment.
postinfection, extracellular virions were collected from the medium by centrifugation through a 30% sucrose cushion at 4°C for 1 h at 83,500 ϫ g in a Beckman SW41 rotor. Total-cell lysates were prepared by resuspending infected cells in sample buffer, followed by sonication. Samples were adjusted to have equal amounts of VP5 (the major capsid protein) so as to ensure that equal numbers of virions and infected-cell lysates were present. All samples were resolved in 11% SDS-PAGE gels and were visualized by Western blotting using the antibodies specified in Fig. 6 , 7, and 9. All experiments were repeated in triplicate. Films were scanned, and bands were subsequently quantified, on a densitometer using Quantity One software.
Immunoprecipitation of UL16. To detect the low levels of UL16 produced in G5 cells, the protein was concentrated and analyzed in a manner similar to that described previously (9) . In brief, cells were infected at an MOI of 5, and after 18 h, they were lysed in a buffer containing 1% NP-40. The lysates were clarified by centrifugation and were subsequently incubated with rabbit anti-UL16 serum with rocking for 1 h at 4°C. Protein G-agarose (Roche) was added, and the solution was incubated for an additional 4 h with rocking at 4°C. Beads were washed 3 times in PBS and were resuspended in SDS sample buffer, and the proteins were resolved by SDS-PAGE. UL16 was visualized with rabbit anti-UL16 serum and horseradish peroxidase (HRP)-conjugated rabbit IgG TrueBlot (eBioscience).
Electron microscopy. Cells were seeded on 60-mm Permanox tissue culture dishes (Nalge Nunc International) 24 h prior to infection with either the WT, ⌬U L 16S, ⌬U L 16B, ⌬U L 16Rev, or ⌬U L 16Rev35 strain at an MOI of 5. At 20 to 24 h postinfection, cells were washed 3 times with ice cold 0.1 M sodium cacodylate and were fixed for 1 h at 4°C in fixation buffer (0.5% [vol/vol] glutaraldehyde, 0.04% [wt/vol] paraformaldehyde, 0.1 M sodium cacodylate). Fixed samples were washed 3 times with 0.1 M sodium cacodylate and were subsequently postfixed in 1% osmium-1.5% potassium ferrocyanide overnight at 4°C. Samples were then washed 3 times in 0.1 M sodium cacodylate, dehydrated with ethyl alcohol (EtOH), and embedded in Epon 812 prior to staining and sectioning. All samples were processed and sectioned in the Microscopy Imaging Facility (Pennsylvania State University College of Medicine) and were visualized using a JEOL JEM-1400 Digital Capture transmission electron microscope.
Electron micrographs of Vero cells infected with the WT or ⌬U L 16S strain were used to quantify and classify cytoplasmic HSV-1 capsids. At least 60 individual micrographs from 3 independent infections (see above) were used, and a total of 1,008 capsids for the WT and 607 capsids for the ⌬U L 16S mutant were observed and were classified as either naked, membrane associated, multicapsid, or mature virions.
Confocal microscopy. Vero cells were transfected with the constructs described in the legend to Fig. 10 and were imaged by confocal microscopy with a Leica TCS SP8 microscope in the Microscopy Imaging Facility (Pennsylvania State University College of Medicine), as described previously (4, 20) . The VP22 constructs used in these experiments (43) were a kind gift of Richard Courtney (Pennsylvania State University). 
RESULTS

Ultrastructural characterization of UL16-null mutants.
Previous studies have suggested a role for UL16 in virion production (15, 17) ; however, the nature of the block that occurs in its absence has not been defined. To address this, we closely examined the wild-type KOS strain and a ⌬U L 16 mutant of the F strain (the ⌬U L 16B virus) by electron microscopy (Fig. 2) . To our surprise, large multicapsid structures were prevalent in Vero cells infected with the ⌬U L 16B mutant (Fig. 2, black arrows) , along with virions of normal appearance (white arrows). These multicapsid structures were largely absent from WT-infected cells, although an occasional aberrant particle could be observed at an extremely low frequency (Fig. 2 , WT, black arrow).
To ascertain whether the abnormal virion structures were HSV strain specific or were due to an unidentified secondary mutation in the ⌬U L 16B virus, another null mutant was made in the KOS strain (the ⌬U L 16S virus). To this end, the U L 16 coding region was deleted from the BAC.KOS plasmid within E. coli, and the resulting genome was subsequently transfected into Vero cells to generate a virus stock. Unlike the ⌬U L 16B virus, which has an imprecise deletion (15) , the ⌬U L 16S mutant lacks all of the U L 16 coding sequence and nothing else. Moreover, the ⌬U L 16S virus was made with minimal passages (see Materials and Methods), whereas the ⌬U L 16B virus was made via traditional selection methods in Vero cells, followed by several rounds of plaque purification (15) , a process that is likely to select unintended mutations. The two mutants produced similar levels of cell-associated and extracellular viruses, but these levels were one-tenth that of the WT at an MOI of 1 (Fig. 3) . Similar growth kinetics were also observed for infections at MOIs of 0.01 and 5, indicating that the phenotype is not multiplicity dependent or due to a delay in viral growth (data not shown). Electron microscopy revealed that the ⌬U L 16S mutant also releases multicapsid virions (Fig. 2) , suggesting that the aberrant particles form as a result of the U L 16 deletion and that the phenotype is not strain specific. In addition, this phenotype does not appear to be cell type dependent, because multicapsid particles were readily observed in both ⌬U L 16S mutant-and ⌬U L 16B mutant-infected HaCaT cells (data not shown).
Within the cytoplasm, vesicles containing multicapsid structures were seen for both ⌬U L 16S virus-and ⌬U L 16B virus-infected Vero cells (Fig. 4 , black arrows). An occasional aberrant particle could be observed in WT-infected cells (Fig. 4) ; however, the vast majority of the capsids were singly enveloped. No defects were observed in DNA packaging or in the egress of capsids from the nucleus. Moreover, no obvious accumulation of cytoplasmic capsids, as seen for mutants that lack UL11 (18) or UL36 (44), was observed. Instead, most of the individual capsids observed in cells infected with the ⌬U L 16S or ⌬U L 16B virus were only partially wrapped with a membrane and were presumably in the midst of secondary envelopment (Fig. 4) . This finding was in contrast to that for WT-infected cells, where the majority of single capsids were observed to be completely enveloped. The various stages of capsid egress were classified and quantified (see Materials and Methods) (Fig. 5 ). The numbers of membrane-free capsids were similar for the WT (48%) and the ⌬U L 16S mutant (41%), but a large reduction was seen in the number of fully wrapped capsids for the mutant (16% versus 44%). Instead, 32% of the ⌬U L 16S capsids appeared to be in the process of acquiring an envelope, compared to only 5% for the WT. Importantly, clusters of capsids were not observed at positions distant from membranes, but many examples of capsid clusters apparently in the act of envelopment were found for the ⌬U L 16S and ⌬U L 16B mutants (Fig. 4) . Thus, the formation of multicapsid virions appears to be the result of a low rate of envelopment after individual capsids arrive at the membrane.
Extensive attempts to quantify the amount of extracellular multicapsid virions biochemically proved unsuccessful. Two different approaches were employed in an effort to separate the multicapsid virions from single virions. Neither flotation nor sedimentation of concentrated extracellular virions through sucrose gradients yielded different separation profiles for WT and ⌬U L 16S virions (data not shown). Because it was necessary to pellet and resuspend the virions prior to these assays, we cannot rule out the possibility that the multicapsid virions are fragile and fell apart during the concentration steps, as was observed for MCMV (45, 46) . Expression and virion packaging of known UL16 binding partners. UL16 has been proposed to exist in a complex with UL11, UL21, and gE, and recent cotransfection studies strongly support this model (4). Because it is well known that the elimination of one viral protein can change the expression and packaging of its binding partners (12, 31, (47) (48) (49) (50) , we examined the amounts of these proteins relative to that of the WT in cell lysates infected with the ⌬U L 16 mutants and in extracellular virions by Western blotting. At least three measurements were made for each protein (results of one experiment are shown in Fig. 6A ). UL11 expression levels were notably reduced in the ⌬U L 16S and ⌬U L 16B mutants (down 57% Ϯ 22% and 58% Ϯ 22%, respectively), but the amounts that were packaged into virions were almost undetectable (reduced by 93% Ϯ 7% and 95% Ϯ 7%) and migrated more slowly than WT UL11 in the gel. No significant alteration in UL21 expression levels could be detected for the ⌬U L 16S and ⌬U L 16B mutants (present at 94% Ϯ 36% and 98% Ϯ 29% of WT levels); however, the levels of virion packaging were drastically reduced (down 89% Ϯ 7% and 92% Ϯ 11%).
For gE, the two U L 16-null viruses produced results completely different from those for UL11 and UL21 (Fig. 6A) . The gE expression level was reduced only slightly for the ⌬U L 16S mutant (present at 81% Ϯ 33% of the WT level), but the amount packaged into virions was dramatically altered (down 91% Ϯ 11%), providing further support for the recently described UL16 -gE interaction (9) . Moreover, cell-associated gE seemed to exhibit less of the slower-migrating, mature glycosylated forms, in agreement with the observation that this glycoprotein is not found on the surfaces of infected cells in the absence of UL16 (4). In contrast, gE levels in cells infected with the ⌬U L 16B virus were below the level of detection by Western blotting, although a very small amount of gE was detected by radiolabeling followed by immunoprecipitation (data not shown). Analysis of the gE coding sequence in the ⌬U L 16B virus revealed no changes, and therefore, at least one other mutation must exist somewhere in this virus. Examination of the parent virus from which the ⌬U L 16B mutant was generated (15, 17) demonstrated a similar reduction in the level of gE expression, suggesting that the mutation responsible for this defect existed prior to the deletion of U L 16. In any case, the collective results for UL11, UL21, and gE were not surprising given the growing evidence that they form a complex with UL16.
Unexpected defects for VP22. Another tegument protein that has long been known to interact with the cytoplasmic tail of gE is VP22 (33, 35, 43) . VP22 also interacts with tegument protein VP16, the product of the U L 48 gene, which is essential for virus replication and egress (28, 34, 51, 52) . Because the level of gE packaging was reduced for the ⌬U L 16S virus, the expression and packaging of VP22 and VP16 were examined. Although no sub- were obtained, and the DNA-filled capsids were counted and classified as either free capsids (not near membranes), membrane-associated capsids, multicapsid virions (2 or more capsids fully wrapped with a single envelope), or mature virions (completely wrapped with a single capsid). Micrographs from 3 independent experiments were used, yielding a total of 1,008 WT capsids and 607 ⌬U L 16S capsids. stantial changes were found for VP16 (Fig. 6B) , VP22 expression was reduced by 38% Ϯ 36% and 64% Ϯ 25% in cells infected with the ⌬U L 16S and ⌬U L 16B viruses, respectively (Fig. 6A) . Moreover, the gel migration of VP22 was slowed in a manner consistent with the previously described hyperphosphorylation state (29, 53) . Unexpectedly, the packaging of VP22 into virions was also found to be greatly reduced, with levels approaching only 2% that of the WT, an reduction that can only partly be attributed to the decrease in protein expression. This result was unexpected, because the packaging of VP22 is not dependent on its phosphorylation state or its ability to interact with VP16 or gE (20, 34, 43, 53) . In fact, deletion of the cytoplasmic tail of gE had no effect on the packaging of VP22 into the virus (Fig. 6C) , as has been reported previously (20) . Thus, VP22 appears to be highly dependent on UL16, although there have been no reports of an interaction (direct or indirect) between these two tegument proteins. This was investigated (see below), but before such investigation, it was essential to ascertain whether the defects we observed were due to the loss of the UL16 protein or were an unintentional consequence of a large deletion altering the expression of nearby genes.
cis-and trans-Complementation of ⌬U L 16 mutants. In the making of HSV mutations, other, unwanted changes sometimes occur, as was found for the ⌬U L 16B mutant (see above). Worries about inadvertent effects are compounded by the fact that U L 16 is located very near to the U L 13 gene, which encodes a kinase that has been shown to modify VP22 (54) (55) (56) . To test the possibility that unintended changes are responsible for the ⌬U L 16S phenotype, two different approaches were used. The first was to infect G5 cells, which contain a section of the HSV-1 genome spanning the region from U L 16 through U L 21 (57) . To confirm that G5 cells can express UL16, they were infected with either the WT, ⌬U L 16S, or ⌬U L 16B viruses (Fig. 7A) . UL16 was absent in control Vero cells, as expected, but it was also below the level of detection of simple immunoblot assays in infected G5 cells. Fortunately, UL16 was readily detected when the protein was concentrated by immunoprecipitation (Fig. 7A) . Despite the low levels of UL16 expression, G5 cells were able to partially restore the composition of ⌬U L 16S virions (Fig. 7B) . In particular, gE, UL21, VP22, and UL11 were readily detected (compare Fig. 7B and 6A) . Moreover, VP22 no longer exhibited the slower-migrating species seen in the lysates from noncomplementing cells. In stark contrast, the only change observed for the ⌬U L 16B mutant in complementing cells was increased packaging of UL21, which provides additional evidence for an unidentified secondary mutation. Surprisingly, G5 cells were able to fully restore the titers of both U L 16-null viruses, as measured in one-step growth curves (Fig. 8A) , but the plaques produced by the ⌬U L 16B mutant remained small (Fig. 8B) , providing still more evidence for a secondary mutation(s).
The second way in which the ⌬U L 16S mutant was analyzed for the presence of unintended alterations was to generate two revertant viruses (Fig. 1) . The ⌬U L 16Rev virus is a true revertant in which the missing gene has been reinserted at its native position. In contrast, the ⌬U L 16Rev35 virus retains the original deletion but has the U L 16 coding sequence inserted in the place of the nonessential U L 35 gene. Except for a 5-fold increase in the expression of UL16 from the more-active U L 35 promoter (12, 58), the two revertant viruses behaved like the WT with regard to their expres- sion and packaging of viral proteins ( Fig. 6A and B) , one-step growth curves (Fig. 8A) , and plaque size (Fig. 8B) .
Electron microscopy was used to see whether the cis-or transcomplemented viruses produce multicapsid virions. No abnormal particles were found in G5 cells infected with either the ⌬U L 16S or ⌬U L 16B mutant, and none were seen in Vero cells infected with the ⌬U L 16Rev or ⌬U L 16Rev35 virus (data not shown). Taken together, all the complementation results demonstrate that the defects in viral replication observed for the ⌬U L 16S mutant-including the defects in VP22 migration and virion packaging-are due solely to the absence of the UL16 protein.
Interaction of UL16 with VP22. The striking changes observed for VP22 when UL16 was absent suggested the possibility that these two tegument proteins interact. As a first step, the U L 49 gene was deleted to create a VP22-null mutant (Fig. 1, ⌬VP22 ) in order to see whether it would be capable of packaging UL16. Additionally, a true revertant (the ⌬VP22Rev strain) was generated to control for any mutations that may have arisen during the recombination process. Previous studies have shown that viruses lacking VP22 replicate poorly and produce small plaques because unregulated VHS leads to altered protein expression (36, 37) , and this was true for the mutant reported here (data not shown). However, although decreases in both gE and VP16 packaging were observed, the absence of VP22 did not affect the expression or packaging of UL16 (Fig. 9) . Thus, it appears that VP22 and UL16 have nonreciprocal packaging requirements (i.e., VP22 is dependent on UL16, but not vice versa), as is the case for VP22 and gE (i.e., VP22 is not dependent on gE, but gE is dependent on VP22).
To look more directly for an interaction between UL16 and VP22, cotransfection assays were used. This method is based on the ability of VP22 to accumulate on microtubules (59) (60) (61) (62) . As a positive control, green fluorescent protein-tagged VP22 (VP22-GFP) was coexpressed with its known binding partner gE. As expected, in cells where VP22-GFP-marked filaments were found, gE was found to colocalize (Fig. 10A) . In the test experiment, VP22 was tagged with an epitope from hemagglutinin (HA), and UL16 was tagged with GFP. When these two proteins were coexpressed, no colocalization was observed (Fig. 10B, top row) ; however, this was not a surprise. UL16 has been shown to be a regulated protein with an N-terminal domain (NTD; residues 1 to 155) that contains binding activities and a C-terminal domain (CTD; residues 156 to 373) that negatively regulates binding. Consequently, the full-length form of UL16 interacts poorly with UL11 and gE unless the CTD is removed (6, 9) . Therefore, each portion of UL16 was individually cotransfected with VP22.HA. As expected, the CTD-GFP construct did not interact with VP22.HA (Fig. 10B , middle row), but the NTD-GFP construct did (bottom row). This suggests that the NTD of UL16 contains the VP22-binding activity, and we presume that it is normally induced when other viral proteins are present. For example, binding of UL21 to full-length UL16 has been shown to enable the UL11 interaction, but UL21 did not stimulate the UL16-VP22 interaction in this study (data not shown) or the interaction with gE (4). Moreover, several amino acid substitutions in the CTD of full-length UL16 have been shown to activate binding to UL11 in the absence of UL21, but these do not activate binding to VP22 (data not shown) or to gE (6) . Nevertheless, the data provided in this report strongly support the hypothesis that UL16 and VP22 can interact in the absence of any other viral proteins, adding yet another member to this growing, but poorly understood, network of UL16 binding partners.
DISCUSSION
HSV-1 assembly brings together 6 capsid proteins, approximately 20 tegument proteins, and 15 membrane proteins (1-3) to create molecular machinery with moving parts that are precisely positioned and regulated to enable many difficult tasks, such as virus entry, delivery of the genome to the nucleus, cell-to-cell spread, and a reverse-signaling event that causes the tegument to be rearranged when the virus binds to its attachment receptors (16) . Moreover, this machinery is adjustable, allowing the virus to meet the distinct challenges of replicating in both epithelial and neuronal cells during the course of its propagation from one individual to another (63) . This complexity presents a daunting task to those who seek to elucidate how this machinery is put together and how it works. Here, two novel observations have been made regarding HSV assembly and the role of the tegument protein UL16. The UL16 -VP22 interaction. The observation that virion packaging of VP22 is dependent on UL16 was unexpected. Indeed, VP22 packaging was found to be far more dependent on UL16 than on its other binding partners, gE (20, 64) and VP16 (34) . This finding then led to the discovery, reported here, that these two molecules can interact in the absence of other viral proteins. In retrospect, it is interesting that in our original search for UL11 binding partners (7), we found variable data to suggest that a small amount of VP22 was obtained in the glutathione S-transferase (GST) pulldown experiments, but we reported only the most abundant and robust binding partner, UL16. Another hint for the interaction was provided by the reduction in the level of VP22 packaging seen when UL11 is absent, which presumably is due to the concomitant failure to package UL16 (20) , since it is now quite clear that VP22 packaging does not require gE (20) , as confirmed here. Also, the slower-migrating, apparently hyperphosphorylated forms of VP22 found in the absence of UL16 are also found in the absence of UL11 or the cytoplasmic tail of gE (20) , providing further evidence that all these proteins work together in a complex. However, the discovery of the UL16 -VP22 interaction offers no particular insight on how any of the viral machinery actually works. Rather, these findings emphasize how little is known about the parts and how they fit together.
Functions for UL16 in cytoplasmic envelopment. The experiments described here show that the obstacle to virion production in the absence of UL16 is encountered after capsids reach cytoplasmic membranes for envelopment. Specifically, it appears that the rate of capsid wrapping is low, leading to the presence of multicapsid virions and a large percentage of membrane-associated, but incomplete, virions. The absence of capsid clusters at positions distant from membranes suggests that individual capsids are sequentially delivered to sites of envelopment, where they are occasionally wrapped as a bundle. This process differs greatly from that observed for the multicapsid virions of gK mutants, which appear to arise by self-fusion of singly enveloped virions within a cytoplasmic vesicle (65, 66) . In those cases, groups of capsids being enveloped simultaneously were not reported. Thus, the findings presented here are consistent with the hypothesis that a bridging function is provided by the UL11-UL16 interaction, with weaker ties between the capsid and the membrane making the wrapping process more difficult.
In seeming contradiction to the bridging hypothesis, the ⌬U L 16 phenotype has not been observed for mutants that lack U L 11. In that case, capsids accumulate free from membranes (reference 18 and data not shown). There are two ways to reconcile this discrepancy within the bridging hypothesis. First, UL16 has been shown to be associated with cytoplasmic capsids (10) , and it may be that the unoccupied, possibly hydrophobic sites that are exposed when this tegument protein is absent result in capsids that are sticky. If so, then capsids would cluster only at cytoplasmic sites where they come together, such as after their individual transport to the membrane. Thus, no clustering would be observed in the absence of UL11, because UL16 would be present on the capsids to occupy the sticky sites.
A second possible explanation for the discrepancy between the ⌬U L 16 and ⌬U L 11 phenotypes is based on the observation that massive disruptions of tegument protein complexes occur when individual components are missing (12, 31, (47) (48) (49) (50) . The present study provides another clear example of this; namely, when UL16 is absent, the packaging of UL11, VP22, and gE is defective. This massive disruption in the molecular machinery could produce delays in capsid envelopment even if the UL11-UL16 interaction itself does not provide a bridging function. On the other hand, in the time since the bridging hypothesis was first put forth, UL16 has been discovered to have a second binding partner on the membrane, gE (9); moreover, UL11 and gE have been shown to interact (20) . Consequently, it is difficult to sort out which interaction with UL16 is more important. In any case, it is quite clear that the primary block to envelopment observed in the absence of UL16 occurs after capsids arrive at the membrane.
Although the presumed bridging function(s) of UL16 is easy to envision, there is another, very different possibility for the role of UL16. This hypothesis is based on a similarity between UL16 and E. coli Hsp33, a chaperone protein that becomes active only when cells are under oxidative stress (67) . Like UL16, Hsp33 has two primary domains. The chaperone activity is located in the N-terminal domain, while the C-terminal domain provides a negative regulatory function. Under oxidizing conditions, a zinc finger provided by four cysteine residues in the regulatory domain is lost, as two disulfide bonds are formed, and the resulting change in conformation activates the chaperone activity (68, 69) . The zinc finger motif of Hsp33 is not found in eukaryotic proteins (70) but is similar to a cysteine motif in the regulatory domain of UL16 (6) . Moreover, it is known that HSV infections induce and require oxidative stress for the production of infectious virions (71) (72) (73) (74) (75) (76) (77) (78) . But unlike those of Hsp33, the binding activities of the N-terminal portion of UL16 seem to be specific for particular viral proteins: UL11 (6), gE (9) , and VP22 (this study). With these observations in mind, it has been proposed that UL16 might serve as a virusspecific chaperone rather than simply providing bridging interactions (6) . This hypothesis is consistent with the observation made here that G5 cells can fully complement the ⌬U L 16S mutation, even though the amount of UL16 produced is below the level of detection by normal Western blotting methods. That is, only a small amount of UL16 might be needed to move from one binding partner to another as it helps weave together the structure of the virion. The need for such a chaperone activity seems likely given the very large number of proteins that must come together to create the complex machinery of the virion. In any case, the reduced packaging of UL16 binding partners into ⌬U L 16S virions from G5 cells is likely due to the limiting amount of this tegument protein available.
The UL16 chaperone hypothesis might also explain the difference in the location of the block to capsid egress between HSV (at the membrane) and human cytomegalovirus (23) , murine cytomegalovirus (24) , and murine gammaherpesvirus 68 (13) , all of which have blocks prior to the transport of their capsids to membranes and are noninfectious as a result. In particular, these viruses may be more dependent on their UL16 homologs for the assembly of tegument proteins onto capsids than is HSV; if so, the misarranged molecules may obscure the sequences that are needed for transport to the membrane. Moreover, this hypothetical difficulty in assembly might explain why the UL16 homologs of beta-and gammaherpesviruses remain stably bound to capsids when their virions are disrupted with NP-40 (14, 79, 80) , whereas the UL16 proteins of alphaherpesviruses do not (10, 16) . Clearly, further studies of these complex tegument proteins are needed in order to sort out their important functions in the replication of herpesviruses.
